News
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
25 Apr 24
Biotech, Large Cap, News, Health Care, Top Stories, General
AbbVie New Data Show RINVOQ Demonstrated Superiority Versus DUPIXENT Across Primary And All Secondary Endpoints In An Open-Label Head-To-Head Atopic Dermatitis Study; Achieved Both A 90% Or Greater Reduction In Eczema Area And Severity Index And A Worst Pruritus Numerical Rating Scale Of 0 Or 1 At Week 16
25 Apr 24
Biotech, News, General
AbbVie's Options Frenzy: What You Need to Know
23 Apr 24
Options, Markets
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
21 Apr 24
Analyst Color, Equities, News, Top Stories, Tech, Trading Ideas
Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
18 Apr 24
Biotech, News, Health Care, Top Stories, General
AbbVie Announces Phase 3 SELECT-GCA Study Of Upadacitinib Results In Patients With Giant Cell Arteritis; In Combination With A 26-week Steroid Taper Regimen Achieved Its Primary Endpoint Of Sustained Remission; Key Secondary Endpoints Were Also Met
18 Apr 24
Biotech, News, General
Is Your Botox Real Or Fake? Counterfeit Boxes Circulate For Widely Used Antiwrinkle Treatment, CDC And FDA Investigate Harmful Reactions
17 Apr 24
Biotech, Large Cap, News, Health Care, FDA, General
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
17 Apr 24
News, Trading Ideas
Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
16 Apr 24
Analyst Color, Biotech, Equities, News, Upgrades, Health Care, Price Target, Analyst Ratings, Movers, Trading Ideas, General
AbbVie's Options Frenzy: What You Need to Know
15 Apr 24
Options, Markets
What's Going On AbbVie Stock On Friday?
12 Apr 24
Movers
Smart Money Is Betting Big In ABBV Options
12 Apr 24
Options, Markets
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA) for Preventive Treatment of Migraine
12 Apr 24
News
Blindness-Focused LENZ Therapeutics' Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst Says
10 Apr 24
Analyst Color, Biotech, News, Health Care, Initiation, Analyst Ratings, Trading Ideas, General
AbbVie Unusual Options Activity For April 05
5 Apr 24
Options, Markets
Smart Money Is Betting Big In ABBV Options
4 Apr 24
Options, Markets
10 Health Care Stocks Whale Activity In Today's Session
3 Apr 24
Options
FibroGen Unveils Early Data From Prostate Cancer Candidate, Analyst Advocates Further Exploration In The Landscape
3 Apr 24
Analyst Color, Biotech, News, Health Care, Analyst Ratings, Movers, Trading Ideas, General
10 Health Care Stocks With Whale Alerts In Today's Session
28 Mar 24
Options
REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet Age-Related Macular Degeneration (AMD)
28 Mar 24
News
Press releases
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
25 Apr 24
Press Releases
Investment Opportunities in Biotech Amidst Federal Rate Uncertainties (ATNM)
22 Apr 24
News, Press Releases
Actinium Pharmaceuticals (ATNM) Leads Biotech Innovation Amid Economic Uncertainty
19 Apr 24
News, Press Releases
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
18 Apr 24
Press Releases
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
12 Apr 24
Press Releases
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
12 Apr 24
Press Releases
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
12 Apr 24
Press Releases
The Law Offices of Frank R. Cruz Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
10 Apr 24
Press Releases
AbbVie to Host First-Quarter 2024 Earnings Conference Call
4 Apr 24
Press Releases
Allergan Aesthetics Announces the Return of CoolMonth with CoolSculpting®
3 Apr 24
Press Releases
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP
27 Mar 24
Press Releases
NIMML Institute's TITAN-X A.I.-Powered Precision Medicine Platform Validated through AbbVie's Acquisition of Landos Biopharma and Lead Clinical Candidate NX-13
25 Mar 24
Press Releases
Allergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in Aesthetics
25 Mar 24
Press Releases
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
25 Mar 24
Press Releases
U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients
22 Mar 24
Press Releases
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
20 Mar 24
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
20 Mar 24
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
20 Mar 24
Parvus Announces Collaboration with AbbVie to Develop IBD Therapies Based on the Parvus Navacim Platform Technology
20 Mar 24
News, Health Care, Press Releases
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
20 Mar 24
News, Press Releases